| Attributes | Values |
|---|
| rdf:type
| |
| description
| - artículu científicu espublizáu en 1999 (ast)
- vědecký článek publikovaný v roce 1999 (cs)
- 1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած (hyw)
- наукова стаття, опублікована в грудні 1999 (uk)
- vedecký článok (publikovaný 1999/12/01) (sk)
- مقالة علمية (نشرت في ديسمبر 1999) (ar)
- 1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված (hy)
- article scientifique publié en 1999 (fr)
- im Dezember 1999 veröffentlichter wissenschaftlicher Artikel (de)
- scientific journal article (en)
- wetenschappelijk artikel (gepubliceerd op 1999/12/01) (nl)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| cites work
| |
| cites work
| - Abacavir: absolute bioavailability, bioequivalence of three oral formulations, and effect of food
- Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides
- Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection
- Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89
- Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.
- Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
- Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
- Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV
- 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity
- Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89
- Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection
- Clinical pharmacokinetics of stavudine
- Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults
- Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection
- Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions
- Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection
|
| author name string
| |
| OpenCitations bibliographic resource ID
| |
| OpenCitations bibliographic resource ID
| |
| author name string
| - J A McDowell
- D S Stein
- R E Polk
- T M Kerkering
- G E Chittick
- J R Ravitch
|
| OpenCitations bibliographic resource ID
| |
| rdfs:label
| - Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (en)
- Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (nl)
- Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (ast)
|
| skos:prefLabel
| - Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (en)
- Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (nl)
- Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (ast)
|
| name
| - Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (en)
- Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (nl)
- Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (ast)
|
| title
| |
| title
| - Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| PMCID
| |
| PMCID
| |
| is about
of | |
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)